Aclarion Corporation - ACON Net earnings per share for the last 12 months

Public company logo of Aclarion Inc (ACON)

The investment potential of Aclarion (ACON) is based on unique MRI spectroscopy algorithms that require extensive validation. The annual EPS (TTM) growth statistics visualize this process, where the value of 99.20 corresponds to the current metric. The foundation is built by competent managers striving to integrate software into US insurance systems, as well as the full automation of NociScan, which allows AI to autonomously identify sources of pain.

Aclarion, Inc. - ACON Earnings per share for the last twelve months (period 02/11/2024 - 11/15/2026)

Aclarion, Inc. - analytical breakdowns and key metrics (ACON)

- market price and analyst price targets:
Market Chart Aclarion, Inc.|ACON - Analyst Consensus Forecast
- issuer market value details:
Market Valuation Aclarion|ACON - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Aclarion|ACON - Company Book Value|Market Cap to Net Assets Ratio aclarion.com|ACON - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital Aclarion|ACON - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio Aclarion|ACON - Company Aggregate Debts|Debts to Net Assets Aclarion Corp|ACON - Company Long-Term Debts|Company Current Liabilities Aclarion|Quick Ratio aclarion.com
- financial results and valuation multiples details:
ACON - Company Net Income|Expected Profit Aclarion|ACON - Price to Earnings Ratio|Future Price to Earnings Multiple Aclarion Corp|ACON - PEG Multiple|Company Value to EBITDA Aclarion Corporation|ACON - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year Aclarion|ACON - Net earnings per share for the last 12 months|Quarterly EPS earnings growth aclarion.com|ACON - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Aclarion
- revenue and sales details:
ACON - Company Revenue|Company Expected Revenue Aclarion Inc|ACON - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Aclarion Corp|ACON - Sales Growth YoY (TTM)
Fundamental company valuation:ACON (Aclarion, Inc.)
Core merchandise of aclarion.com

An analysis of Aclarion (ACON) via trailing twelve-month (TTM) EPS growth statistics reveals the dynamics of net profit per share over a rolling year. This indicator captures the percentage change in earnings, incorporating daily market liquidity to determine fundamental momentum. The metric's high sensitivity to one-off shifts necessitates an evaluation of the overall trend rather than isolated data points. For a company whose specialized software is shielded from US geopolitical risks, this figure reflects pure operational growth. A stable earnings trajectory confirms the resilience of the business model within a neutral regulatory environment.

Competitor analysis for Aclarion

Abbott Laboratories Inc. (ABT) - Net earnings per share for the last 12 months|TMO (Thermo Fisher Corp) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months GE HealthCare|Earnings per share for the last twelve months mt.com|Net earnings per share for the last 12 months Waters Corporation (WAT)|Earnings per share for the last twelve months Bio-Techne Corp (TECH)|Net earnings per share for the last 12 months Bruker BRKR|Net earnings per share (EPS TTM) AZTA (azenta.com)|Varex (VREX) - Net earnings per one share for the last twelve months|Semler Scientific - Net earnings per share (EPS TTM)|BFLY (Butterfly Network, Inc.) - Earnings per share for the last 12 months|MLAB: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Quantum-Si Incorporated|NNOX (Nano-X Imaging Ltd) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Quanterix Corp (QTRX)|Net earnings per share (EPS TTM) MASS|CV (CapsoVision) - Earnings per share for the trailing year|Earnings per share for the last twelve months MaxCyte MXCT|rapidmicrobio.com - Earnings per share for the last twelve months|SEER: Net earnings per share for the last 12 months|Earnings per share for the trailing year HYPR (Hyperfine Corp)|FONR: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Daxor Corporation DXR|Earnings per share for the last twelve months Spectral AI Inc.|VIVS - Net earnings per share for the trailing year|Net earnings per share for the last 12 months AKYA (akoyabio.com)|Net earnings per share (EPS TTM) ThermoGenesis Holdings Inc. (THMO)|Net earnings per share (EPS TTM) TLIS (talis.bio)|Net earnings per share for the last four quarters t2biosystems.com (TTOO)